Evidence map›Paper›PMID 19086274›Full record

ArticleBiochemistry2008

The intrinsically disordered RNR inhibitor Sml1 is a dynamic dimer.

Jens Danielsson, Leena Liljedahl, Elsa Bárány-Wallje, Pernille Sønderby, Line Hyltoft Kristensen, Maria A Martinez-Yamout, H Jane Dyson, Peter E Wright, Flemming M Poulsen, Lena Mäler and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jens DanielssonDepartment of Biochemistry and Biophysics, Stockholm University, S-106 91 Stockholm, Sweden.
Leena Liljedahl
Elsa Bárány-Wallje
Pernille Sønderby
Line Hyltoft Kristensen
Maria A Martinez-Yamout
H Jane Dyson
Peter E Wright
Flemming M Poulsen
Lena Mäler
Astrid Gräslund
Birthe B Kragelund
University of Copenhagen · DKScripps Research Institute · USStockholm University · SE

Funding

UNFOLDED STATES AND FOLDING PATHWAYS BY NMRR01GM057374 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DYSON, HELEN JANE · 1998 to 2011
$3.5M
NIGMS NIH HHS GM7374NIGMS NIH HHS R01 GM057374
6 · The paper itself

Abstract

Sml1 is a small ribonucleotide reductase (RNR) regulatory protein in Saccharomyces cerevisiae that binds to and inhibits RNR activation. NMR studies of 15N-labeled Sml1 (104 residues), as well as of a truncated variant (residues 50-104), have allowed characterization of their molecular properties. Sml1 belongs to the class of intrinsically disordered proteins with a high degree of dynamics and very little stable structure. Earlier suggestions for a dimeric structure of Sml1 were confirmed, and from translation diffusion NMR measurements, a dimerization dissociation constant of 0.1 mM at 4 degreesC could be determined. The hydrodynamic radius for the monomeric form of Sml1 was determined to be 23.4 A, corresponding to a protein size between those of a globular protein and a coil. Formation of a dimer results in a hydrodynamic radius of 34.4 A. The observed chemical shifts showed in agreement with previous studies two segments with transient helical structure, residues 4-20 and 60-86, and relaxation studies clearly showed restricted motion in these segments. A spin-label attached to C14 showed long-range interactions with residues 60-70 and 85-95, suggesting that the N-terminal domain folds onto the C-terminal domain. Importantly, protease degradation studies combined with mass spectrometry indicated that the N-terminal domain is degraded before the C-terminal region and thus may serve as a protection against proteolysis of the functionally important C-terminal region. Dimer formation was not associated with significant induction of structure but was found to provide further protection against proteolysis. We propose that this molecular shielding and protection of vital functional structures from degradation by functionally unimportant sites may be a general attribute of other natively disordered proteins.

Indexed as

Amino Acid SequenceConserved SequenceDimerizationMolecular Sequence DataPeptide FragmentsProtein BindingProtein Structure, TertiaryRibonucleotide ReductasesSaccharomyces cerevisiae ProteinsThermodynamicsPeptide FragmentsRibonucleotide ReductasesSaccharomyces cerevisiae ProteinsSML1 protein, S cerevisiae

Identifiers

PMID19086274
PMCPMC2747730
OpenAlexW2089393102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.